Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer

D. S. Howard, D. A. Rizzierri, B. Grimes, D. Upchurch, G. L. Phillips, Alexander Keith Stewart, J. R. Yannelli, C. T. Jordan

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Gene transfer into early hematopoietic cells has been problematic due to the quiescent nature of primitive cells and the lack of gene transfer vehicles with high efficiency for hematopoietic cell types. Previously, we have shown that adenoviral vectors can be used for the transduction of normal human progenitors with gene transfer efficiencies of approximately 30%. However, this approach is limited by relatively slow uptake kinetics (24-48 h) and a strong dependence on the presence of exogenous cytokines. Thus, we have modified this approach by combining adenoviral vectors with polycations to generate a virus-polycation complex, or VPC. Vehicles of this nature, when composed of conventional adenoviral vectors and polyamidoamine dendrimers, are a highly efficient means of transducing both normal and acute myelogenous leukemia (AML) cells. Moreover, the kinetics of gene transfer are markedly increased using the VPC strategy, with approximately 70% of transduction complete within 2 h. In this study, using viruses that encode green fluorescence protein (GFP), or the T cell costimulatory molecule B7.1 (CD80), we show that VPC-mediated gene transfer is an effective means of transducing normal and AML cells, including those with a highly primitive phenotype. Our data suggest that transient genetic manipulation of primitive hematopoietic cells can readily be achieved and should therefore permit a variety of research and clinical endeavors.

Original languageEnglish (US)
Pages (from-to)1608-1616
Number of pages9
JournalLeukemia
Volume13
Issue number10
StatePublished - 1999
Externally publishedYes

Fingerprint

Adenoviridae
Genes
Acute Myeloid Leukemia
Viruses
Dendrimers
Fluorescence
Cytokines
T-Lymphocytes
Phenotype
Research
Proteins

Keywords

  • Acute myelogenous leukemia (AML)
  • Adenovirus
  • CD80
  • Gene transfer
  • Hematopoietic
  • Leukemia

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

Howard, D. S., Rizzierri, D. A., Grimes, B., Upchurch, D., Phillips, G. L., Stewart, A. K., ... Jordan, C. T. (1999). Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer. Leukemia, 13(10), 1608-1616.

Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer. / Howard, D. S.; Rizzierri, D. A.; Grimes, B.; Upchurch, D.; Phillips, G. L.; Stewart, Alexander Keith; Yannelli, J. R.; Jordan, C. T.

In: Leukemia, Vol. 13, No. 10, 1999, p. 1608-1616.

Research output: Contribution to journalArticle

Howard, DS, Rizzierri, DA, Grimes, B, Upchurch, D, Phillips, GL, Stewart, AK, Yannelli, JR & Jordan, CT 1999, 'Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer', Leukemia, vol. 13, no. 10, pp. 1608-1616.
Howard, D. S. ; Rizzierri, D. A. ; Grimes, B. ; Upchurch, D. ; Phillips, G. L. ; Stewart, Alexander Keith ; Yannelli, J. R. ; Jordan, C. T. / Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer. In: Leukemia. 1999 ; Vol. 13, No. 10. pp. 1608-1616.
@article{9bac163785e4424aaa8f97c2e3e983c1,
title = "Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer",
abstract = "Gene transfer into early hematopoietic cells has been problematic due to the quiescent nature of primitive cells and the lack of gene transfer vehicles with high efficiency for hematopoietic cell types. Previously, we have shown that adenoviral vectors can be used for the transduction of normal human progenitors with gene transfer efficiencies of approximately 30{\%}. However, this approach is limited by relatively slow uptake kinetics (24-48 h) and a strong dependence on the presence of exogenous cytokines. Thus, we have modified this approach by combining adenoviral vectors with polycations to generate a virus-polycation complex, or VPC. Vehicles of this nature, when composed of conventional adenoviral vectors and polyamidoamine dendrimers, are a highly efficient means of transducing both normal and acute myelogenous leukemia (AML) cells. Moreover, the kinetics of gene transfer are markedly increased using the VPC strategy, with approximately 70{\%} of transduction complete within 2 h. In this study, using viruses that encode green fluorescence protein (GFP), or the T cell costimulatory molecule B7.1 (CD80), we show that VPC-mediated gene transfer is an effective means of transducing normal and AML cells, including those with a highly primitive phenotype. Our data suggest that transient genetic manipulation of primitive hematopoietic cells can readily be achieved and should therefore permit a variety of research and clinical endeavors.",
keywords = "Acute myelogenous leukemia (AML), Adenovirus, CD80, Gene transfer, Hematopoietic, Leukemia",
author = "Howard, {D. S.} and Rizzierri, {D. A.} and B. Grimes and D. Upchurch and Phillips, {G. L.} and Stewart, {Alexander Keith} and Yannelli, {J. R.} and Jordan, {C. T.}",
year = "1999",
language = "English (US)",
volume = "13",
pages = "1608--1616",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer

AU - Howard, D. S.

AU - Rizzierri, D. A.

AU - Grimes, B.

AU - Upchurch, D.

AU - Phillips, G. L.

AU - Stewart, Alexander Keith

AU - Yannelli, J. R.

AU - Jordan, C. T.

PY - 1999

Y1 - 1999

N2 - Gene transfer into early hematopoietic cells has been problematic due to the quiescent nature of primitive cells and the lack of gene transfer vehicles with high efficiency for hematopoietic cell types. Previously, we have shown that adenoviral vectors can be used for the transduction of normal human progenitors with gene transfer efficiencies of approximately 30%. However, this approach is limited by relatively slow uptake kinetics (24-48 h) and a strong dependence on the presence of exogenous cytokines. Thus, we have modified this approach by combining adenoviral vectors with polycations to generate a virus-polycation complex, or VPC. Vehicles of this nature, when composed of conventional adenoviral vectors and polyamidoamine dendrimers, are a highly efficient means of transducing both normal and acute myelogenous leukemia (AML) cells. Moreover, the kinetics of gene transfer are markedly increased using the VPC strategy, with approximately 70% of transduction complete within 2 h. In this study, using viruses that encode green fluorescence protein (GFP), or the T cell costimulatory molecule B7.1 (CD80), we show that VPC-mediated gene transfer is an effective means of transducing normal and AML cells, including those with a highly primitive phenotype. Our data suggest that transient genetic manipulation of primitive hematopoietic cells can readily be achieved and should therefore permit a variety of research and clinical endeavors.

AB - Gene transfer into early hematopoietic cells has been problematic due to the quiescent nature of primitive cells and the lack of gene transfer vehicles with high efficiency for hematopoietic cell types. Previously, we have shown that adenoviral vectors can be used for the transduction of normal human progenitors with gene transfer efficiencies of approximately 30%. However, this approach is limited by relatively slow uptake kinetics (24-48 h) and a strong dependence on the presence of exogenous cytokines. Thus, we have modified this approach by combining adenoviral vectors with polycations to generate a virus-polycation complex, or VPC. Vehicles of this nature, when composed of conventional adenoviral vectors and polyamidoamine dendrimers, are a highly efficient means of transducing both normal and acute myelogenous leukemia (AML) cells. Moreover, the kinetics of gene transfer are markedly increased using the VPC strategy, with approximately 70% of transduction complete within 2 h. In this study, using viruses that encode green fluorescence protein (GFP), or the T cell costimulatory molecule B7.1 (CD80), we show that VPC-mediated gene transfer is an effective means of transducing normal and AML cells, including those with a highly primitive phenotype. Our data suggest that transient genetic manipulation of primitive hematopoietic cells can readily be achieved and should therefore permit a variety of research and clinical endeavors.

KW - Acute myelogenous leukemia (AML)

KW - Adenovirus

KW - CD80

KW - Gene transfer

KW - Hematopoietic

KW - Leukemia

UR - http://www.scopus.com/inward/record.url?scp=0032855019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032855019&partnerID=8YFLogxK

M3 - Article

C2 - 10516763

AN - SCOPUS:0032855019

VL - 13

SP - 1608

EP - 1616

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 10

ER -